Back to top
more

Tilray Brands (TLRY)

(Delayed Data from NSDQ)

$0.61 USD

0.61
18,846,675

+0.04 (6.88%)

Updated Aug 4, 2025 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (155 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Company News for Mar 4, 2020

by Zacks Equity Research

Companies in the news are: SCON, OMER, QGEN, TLRY

Zacks Equity Research

Tilray, Inc. (TLRY) Reports Q4 Loss, Misses Revenue Estimates

by Zacks Equity Research

Tilray, Inc. (TLRY) delivered earnings and revenue surprises of -82.35% and -15.20%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports fourth-quarter 2019 results.

Payel Dhar headshot

Implied Volatility Surging for Tilray (TLRY) Stock Options

by Payel Dhar

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

Sanghamitra Saha headshot

What Do Canopy Earnings Say About Cannabis ETFs?

by Sanghamitra Saha

Solid earnings drive Canopy Growth stock and boost the industry as a result. Is it right time to buy marijuana ETFs?

Zacks Equity Research

Tilray, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Tilray, Inc. (TLRY) closed at $17.78 in the latest trading session, marking a +1.08% move from the prior day.

Zacks Equity Research

Zacks Market Edge Highlights: Amazon, Tesla, Beyond Meat, Ferrari and Tilray

by Zacks Equity Research

Zacks Market Edge Highlights: Amazon, Tesla, Beyond Meat, Ferrari and Tilray

Tracey Ryniec headshot

Tesla Euphoria: Signal of a Market Top?

by Tracey Ryniec

With Tesla price targets flying high, some investors are having flashbacks to analyst upgrades on Amazon in 1998 that signaled an overheated stock market.

Zacks Equity Research

Tilray, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Tilray, Inc. (TLRY) closed at $19.22, marking a +1.53% move from the previous day.

Zacks Equity Research

Options Traders Expect Huge Moves in Tilray (TLRY) Stock

by Zacks Equity Research

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

Zacks Equity Research

Tilray (TLRY) in Focus: Stock Moves 9% Higher

by Zacks Equity Research

Tilray (TLRY) shares rose 9% in the last trading session, amid huge volumes.

Benjamin Rains headshot

5 Cheap Stocks Trading Under $20 to Buy for 2020

by Benjamin Rains

Let's dive into five strong stocks currently trading for under $20 per share we found with our Zacks Stock Screener that investors might want to buy for 2020...

Urmimala Biswas headshot

Ride the Cannabis Wave With These 3 Stocks

by Urmimala Biswas

Here we discuss three best stocks in the emerging cannabis space.

Zacks Equity Research

Do Options Traders Know Something About Tilray (TLRY) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

Sanghamitra Saha headshot

Is REX Shares' Leveraged Cannabis ETN Launch Untimely?

by Sanghamitra Saha

REX Shares has launched two cannabis-related ETNs, one among which is double leveraged. Is the launch untimely?

Zacks Equity Research

Tilray (TLRY) Looks Good: Stock Adds 7.2% in Session

by Zacks Equity Research

Tilray (TLRY) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Sanghamitra Saha headshot

Marijuana ETFs Bounce Back: Can the Rally Last?

by Sanghamitra Saha

Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.

Zacks Equity Research

What's in the Cards for OrganiGram (OGI) in Q4 Earnings?

by Zacks Equity Research

According to OrganiGram (OGI), there is hugely unmet consumer demand for CBD products.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Tilray, Canopy Growth and Aurora Cannabis

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Tilray, Canopy Growth and Aurora Cannabis

Sanghamitra Saha headshot

Can Bill Hopes Relieve Earnings-Induced Pain in Pot ETFs?

by Sanghamitra Saha

A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.

Zacks Equity Research

Implied Volatility Surging for Tilray (TLRY) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

Madeleine Johnson headshot

Why Marijuana Stocks Plummeted in 2019

by Madeleine Johnson

Marijuana stocks were on a tear last year, but 2019 has sent stock tumbling back down to Earth. What happened?

Zacks Equity Research

Tilray, Inc. (TLRY) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Tilray, Inc. (TLRY) delivered earnings and revenue surprises of -72.41% and 3.05%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Tracey Ryniec headshot

5 Trendy Earnings Charts

by Tracey Ryniec

Are cannabis and solar stocks still the place to be for traders in 2019?

Zacks Equity Research

Chegg, C.H. Robinson Worldwide, Tilray, Anheuser-Busch InBev and Novartis highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Chegg, C.H. Robinson Worldwide, Tilray, Anheuser-Busch InBev and Novartis highlighted as Zacks Bull and Bear of the Day